Incidence of COVID-19 among individuals vaccinated with ChAdOx1 nCoV-19 vaccine (recombinant) against SARS-CoV-2 at a tertiary health care centre in Telangana

Indian J Med Res. 2022 Jan;155(1):211-213. doi: 10.4103/ijmr.ijmr_1626_21.

Authors

Prashant Ramdas Kokiwar¹, Bhadra Reddy², Preeti Reddy², Siddappa Gowrav³, Chandrakant Shirole⁴

Affiliations

¹ Department of Community Medicine, Malla Reddy Institute of Medical Sciences, Hyderabad 500 055, Telangana, India.
² Department of General Medicine, Malla Reddy Institute of Medical Sciences, Hyderabad 500 055, Telangana, India.
³ Department of Anesthesiology, Malla Reddy Institute of Medical Sciences, Hyderabad 500 055, Telangana, India.
⁴ Department of Physiology, Malla Reddy Institute of Medical Sciences, Hyderabad 500 055, Telangana, India.

No abstract available

MeSH terms

COVID-19* / prevention & control
ChAdOx1 nCoV-19
Delivery of Health Care
Humans
Incidence
SARS-CoV-2*

Substances

ChAdOx1 nCoV-19